0000921895-22-001555.txt : 20220510
0000921895-22-001555.hdr.sgml : 20220510
20220510171349
ACCESSION NUMBER: 0000921895-22-001555
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220506
FILED AS OF DATE: 20220510
DATE AS OF CHANGE: 20220510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Green James W
CENTRAL INDEX KEY: 0001400121
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33957
FILM NUMBER: 22910985
MAIL ADDRESS:
STREET 1: 12525 CHADRON AVENUE
CITY: HAWTHORNE
STATE: CA
ZIP: 90250
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HARVARD BIOSCIENCE INC
CENTRAL INDEX KEY: 0001123494
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 043306140
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 84 OCTOBER HILL RD
CITY: HOLLISTON
STATE: MA
ZIP: 01746
BUSINESS PHONE: 5088938999
MAIL ADDRESS:
STREET 1: 84 OCTOBER HILL ROAD
CITY: HOLLISTON
STATE: MA
ZIP: 01746
4
1
form412799001_05102022.xml
OWNERSHIP DOCUMENT
X0306
4
2022-05-06
0
0001123494
HARVARD BIOSCIENCE INC
HBIO
0001400121
Green James W
C/O HARVARD BIOSCIENCE, INC.
84 OCTOBER HILL ROAD
HOLLISTON
MA
01746
1
1
0
0
Chief Executive Officer
Common Stock
2022-05-06
4
P
0
30000
3.78
A
2309955
D
Common Stock
2022-05-09
4
P
0
10000
3.40
A
2319955
D
This transaction was executed in multiple trades at prices ranging from $3.705 to $3.845, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes (a) 157,037 restricted stock units that will vest in three equal installments on December 29, 2022, 2023 and 2024, (b) 218,140 remaining restricted stock units that will vest on June 11, 2022 and 2023, (c) 129,799 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (d) 109,070 remaining restricted stock units that will vest on December 29, 2022 and 2023, (e) 104,590 remaining restricted stock units that will vest on January 1, 2023, (f) 541,218 restricted stock units with performance based vesting conditions tied to relative total shareholder return and (g) 1,050,101 shares of common stock beneficially owned by the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $3.375 to $3.41, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes (a) the shares and awards described in footnote (2) above, and (b) the shares purchased in the transaction described in footnote (3) above.
/s/ David Sirois, by power of attorney
2022-05-10